Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
For information on drug expiration / generic availability
— Pharmacist, USA
To confirm freedom to operate for drugs
— Drug development consultant, USA
To get information on international drug patents
— Patent agent, USA
To plan ahead for inventory purposes
— Pharmacy purchaser, USA
To proactively manage the hospital's pharmaceutical inventory
— Hospital pharmacist, USA
Generated: May 27, 2017
| Tradename: | 1 |
| Applicant: | 1 |
| Ingredient: | 1 |
| Patents: | 1 |
| Therapeutic Class: | Antibacterials |
| Formulation / Manufacturing: | see details |
| Ingredient-type | Aminoglycosides |
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
TOBI |
tobramycin |
SOLUTION;INHALATION | 050753 | NDA | Novartis Pharmaceuticals Corporation | 0078-0494 | 0078-0494-71 | 56 POUCH in 1 CARTON (0078-0494-71) > 4 AMPULE in 1 POUCH (0078-0494-91) > 5 mL in 1 AMPULE (0078-0494-61) |
TOBI |
tobramycin |
SOLUTION;INHALATION | 050753 | NDA AUTHORIZED GENERIC | Sandoz Inc | 0781-7171 | 0781-7171-56 | 56 AMPULE in 1 CARTON (0781-7171-56) > 5 mL in 1 AMPULE (0781-7171-75) |
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INHALATION | Strength | 300MG/5ML | ||||
| Approval Date: | Dec 22, 1997 | TE: | AN | RLD: | Yes | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis Pharms | TOBI | tobramycin | SOLUTION;INHALATION | 050753-001 | Dec 22, 1997 | 5,508,269 | ► Subscribe | ||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
To obtain drug patent expiration dates for Switzerland
— Patent attorney, Switzerland
To have a global perspective of drug product patents
— Generic drug product company R&D manager, Spain
To identify patent expiration dates
— Medicine sourcing, Malaysia
To get full text for drug patents
— Researcher, Belarus
To find examples of compounds losing patent protection in 2016-2019
— Researcher, Poland
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
